AstraZeneca says Imfinzi combo shows promise in late-stage lung cancer trial
AstraZeneca said on Thursday a combination of its cancer drug, Imfinzi, and chemotherapy showed promise in a late-stage trial in patients with an aggressive form of lung cancer, when given before surgery.